Skip to main content

BioAge Labs, Inc 8-K, filed Nov 5, 2026

BioAge Labs, Inc. (BIOA)

8-K 2026-11-05 For: 2026-11-05
View Original
Added on November 05, 2026

About this 8-K

BioAge Labs, Inc filed this 8-K on November 5, 2026.

BioAge reported a net loss of $33.5 million for the quarter ended September 30, 2026 and approximately $352.3 million in cash, cash equivalents, and marketable securities. QUELL-CV topline data are anticipated in the fourth quarter of 2026, with funding projected through 2029. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits